Nordson
NDSN Nasdaq Industrial Machinery & Supplies & Components Financials FY2016βFY2025
Nordson's revenue rose 3.8% to $2.8 billion in fiscal 2025. Its operating margin was 25.5%, up from 25.1% a year earlier. Free cash flow was $661 million, up 34.4%. It paid out $485 million in dividends and buybacks, 73% of free cash flow. The diluted share count fell 1.2%.
What Nordson does
No business description yet.
- Legal name
- NORDSON CORPORATION
- Fiscal year ends
- October 31, 2025
- Latest annual report
- β
- Accession Β· CIK
- 0000072331-25-000144
0000072331
Revenue and margins
Nordson had $2.8B of revenue in fiscal 2025, up 3.8% on the year before.
Net income and earnings per share
From fiscal 2016 to 2025, diluted EPS grew 6.7% a year. Loss periods are shown in red.
Returns on capital
After-tax operating income as a share of the money invested in the business: debt plus equity, minus cash.
Cash flow
Free cash flow was $661M in fiscal 2025, 23.7% of revenue. Cash from operations minus capital spending.
Dividends, buybacks and share count
Nordson returned $485M to shareholders in fiscal 2025, 73% of free cash flow. The diluted share count fell 1.2%.
Value Nordson yourself
Change the assumptions and see what they imply per share. These are models, not forecasts or price targets β the answer depends entirely on what you put in.
Discounted cash flow
Value per share
β
Adds net cash of β$1.9B and divides by 56.9M diluted shares. Ten years of cash flows plus a terminal value, discounted to today.
Earnings multiple
Value per share
β
Reference multiples: today 32.3x Β· peers 25.1x Β· sector 26.0x.
Balance sheet
Cash, debt and the ratios that show how comfortably Nordson can carry it.
| Fiscal year end | FY21 | FY22 | FY23 | FY24 | FY25 |
|---|---|---|---|---|---|
| Cash and short-term investments | $300M | $164M | $116M | $116M | $108M |
| Debt incl. finance leases | $833M | $754M | $1.7B | $2.2B | $2.0B |
| Net debt / EBITDA | 0.7x | 0.7x | 2.2x | 2.8x | 2.4x |
| Debt / equity | 0.4x | 0.3x | 0.7x | 0.8x | 0.7x |
| Interest coverage | 24.1x | 31.3x | 11.3x | 7.6x | 6.8x |
| Current ratio | 2.6x | 1.4x | 2.1x | 2.4x | 1.6x |
| Quick ratio | 1.9x | 0.9x | 1.3x | 1.5x | 1.1x |
| Total assets | $3.8B | $3.8B | $5.3B | $6.0B | $5.9B |
| Total liabilities | $1.6B | $1.5B | $2.7B | $3.1B | $2.9B |
| Shareholders' equity | $2.2B | $2.3B | $2.6B | $2.9B | $3.0B |
| Net debt (β = net cash) | $533M | $590M | $1.6B | $2.1B | $1.9B |
Insider trades
Open-market purchases and sales by officers, directors and 10% owners, from Form 4 filings. 'Plan' marks trades under a pre-arranged Rule 10b5-1 plan.
Bought, 12 months
$0.0M
0 insiders
Sold, 12 months
$25.6M
9 insiders
Of sales under plans
12%
$3.0M
| Date | Insider | Trade | Shares | Price | Value | Filing |
|---|---|---|---|---|---|---|
| Oct 14, 2026 | Milton Mayo MorrisDirector | Sold | 255 | $327.20 | $0.1M | Form 4 |
| Sep 15, 2026 | Joseph M RutledgeVP, CAO | Sold | 684 | $309.38 | $0.2M | Form 4 |
| Sep 2, 2026 | Milton Mayo MorrisDirector | Sold | 156 | $316.63 | $0.0M | Form 4 |
| Aug 27, 2026 | Jennifer L McDonoughEVP, GC, and Secretary | Sold | 260 | $336.00 | $0.1M | Form 4 |
| Aug 26, 2026 | Daniel Roy HopgoodEVP, CFO | Sold | 1,329 | $334.29 | $0.4M | Form 4 |
| Apr 17, 2026 | Srinivas SubramanianExecutive Vice President | Sold plan | 3,100 | $280.00 | $0.9M | Form 4 |
| Apr 15, 2026 | Milton Mayo MorrisDirector | Sold | 245 | $273.87 | $0.1M | Form 4 |
| Apr 8, 2026 | Justin E HallEVP | Sold | 716 | $275.82 | $0.2M | Form 4 |
| Feb 24, 2026 | Joseph P KelleyExecutive Vice President | Sold | 8,725 | $293.04 | $2.6M | Form 4 |
| Feb 24, 2026 | Sundaram NagarajanPresident and CEO, Director | Sold | 41,800 | $293.26 | $12.3M | Form 4 |
| Feb 23, 2026 | Joseph P KelleyExecutive Vice President | Sold | 23,052 | $289.31 | $6.7M | Form 4 |
| Nov 10, 2025 | James E DeVriesExecutive Vice President | Sold plan | 9,100 | $233.60 | $2.1M | Form 4 |
Piotroski F-score
Nine pass/fail tests of profitability, funding and efficiency. 8β9 is strong, 0β2 weak.
| Test | FY23 | FY24 | FY25 |
|---|---|---|---|
| Net income is positive | β | β | β |
| Cash from operations is positive | β | β | β |
| Return on assets rose | β | β | β |
| Cash from operations exceeds net income | β | β | β |
| Debt fell relative to assets | β | β | β |
| Current ratio rose | β | β | β |
| Share count didn't rise | β | β | β |
| Gross margin rose | β | β | β |
| Revenue rose relative to assets | β | β | β |
| F-score | 6 / 9 | 6 / 9 | 5 / 9 |
| Accruals ratio | β3.4% | β1.6% | β3.9% |
| Altman Z'' | 5.17 | 4.91 | 4.99 |
Similar companies
Each company's latest fiscal year. Fiscal years end in different months, so periods don't line up exactly.
| Company | Market cap | Growth | Op. margin | FCF margin | ROIC | P/E | F-score | |
|---|---|---|---|---|---|---|---|---|
| Nordson NDSN | $17.9B | 3.8% | 25.5% | 23.7% | 11.6% | 32.3x | 5 | |
| ESAB ESAB | $4.1B | 3.7% | 14.5% | 7.5% | 11.0% | 24.1x | 4 | Compare β |
| Carpenter Technology CRS | $14.2B | 8.6% | 22.5% | 11.6% | 23.7% | 25.1x | 9 | Compare β |
| Middleby MIDD | $5.1B | 1.6% | 18.0% | 17.5% | 8.7% | β | 4 | Compare β |
| Crane CR | $10.7B | 8.2% | 18.4% | 14.8% | 15.2% | 32.0x | 6 | Compare β |
10 years of figures
US$ millions unless stated. Hover a ratio's name for its definition.
| Fiscal year | FY16 | FY17 | FY18 | FY19 | FY20 | FY21 | FY22 | FY23 | FY24 | FY25 |
|---|---|---|---|---|---|---|---|---|---|---|
| Income statement | ||||||||||
| Revenue | $1.8B | $2.1B | $2.3B | $2.2B | $2.1B | $2.4B | $2.6B | $2.6B | $2.7B | $2.8B |
| Gross profit | $994M | $1.1B | $1.2B | $1.2B | $1.1B | $1.3B | $1.4B | $1.4B | $1.5B | $1.5B |
| Research and development | $46.2M | $52.5M | $58.8M | $60.0M | $63.6M | $59.4M | $52.5M | $71.4M | $65.0M | $68.2M |
| Operating income | $388M | $466M | $503M | $483M | $350M | $615M | $702M | $673M | $674M | $712M |
| Interest expense | $21.3M | $36.6M | $49.6M | $47.1M | $32.2M | $25.5M | $22.4M | $59.5M | $88.9M | $104M |
| Pretax income | $369M | $420M | $449M | $431M | $302M | $574M | $649M | $615M | $586M | $598M |
| Income tax | $96.7M | $125M | $71.1M | $94.0M | $51.9M | $120M | $136M | $128M | $118M | $113M |
| Net income | $272M | $296M | $377M | $337M | $250M | $454M | $513M | $488M | $467M | $485M |
| Diluted EPS | $4.73 | $5.08 | $6.40 | $5.79 | $4.27 | $7.74 | $8.81 | $8.46 | $8.11 | $8.51 |
| Diluted shares | 0.06B | 0.06B | 0.06B | 0.06B | 0.06B | 0.06B | 0.06B | 0.06B | 0.06B | 0.06B |
| Cash flow | ||||||||||
| Cash from operations | $335M | $357M | $505M | $383M | $502M | $546M | $513M | $641M | $556M | $719M |
| Capital expenditure | $60.9M | $71.6M | $89.8M | $64.2M | $50.5M | $38.3M | $51.4M | $34.6M | $64.4M | $58.1M |
| Free cash flow | $274M | $285M | $415M | $319M | $452M | $508M | $462M | $607M | $492M | $661M |
| Depreciation and amortization | $70.3M | $90.9M | $108M | $110M | $113M | $104M | $99.9M | $59.7M | $77.0M | $79.3M |
| Stock-based compensation | $18.2M | $20.2M | $21.6M | $18.1M | $12.9M | $22.8M | $30.7M | $22.7M | $19.0M | $18.9M |
| Acquisitions | $42.6M | $806M | $50.6M | $12.5M | $142M | $0.0M | $172M | $1.4B | $790M | $0.0M |
| Share buybacks | $33.4M | $3.2M | $24.0M | $121M | $52.6M | $61.0M | $263M | $89.7M | $33.3M | $306M |
| Dividends paid | $56.4M | $63.8M | $72.4M | $82.1M | $88.3M | $97.7M | $126M | $150M | $161M | $179M |
| Dividends and buybacks | $89.9M | $67.1M | $96.5M | $203M | $141M | $159M | $389M | $240M | $195M | $485M |
| Balance sheet | ||||||||||
| Cash and short-term investments | $67.2M | $90.4M | $95.7M | $151M | $208M | $300M | $164M | $116M | $116M | $108M |
| Total debt | $981M | $1.6B | $1.3B | $1.2B | $1.1B | $812M | $738M | $1.7B | $2.2B | $2.0B |
| Finance lease liabilities | $0.0M | $0.0M | $0.0M | $14.9M | $16.5M | $20.7M | $16.1M | $16.6M | $17.3M | $14.3M |
| Current assets | $746M | $888M | $884M | $1.0B | $1.0B | $1.2B | $1.1B | $1.2B | $1.3B | $1.2B |
| Current liabilities | $332M | $648M | $350M | $478M | $363M | $445M | $834M | $582M | $529M | $758M |
| Inventory | $220M | $264M | $265M | $283M | $277M | $327M | $383M | $455M | $477M | $445M |
| Property and equipment, net | $273M | $346M | $387M | $399M | $359M | $356M | $353M | $393M | $545M | $517M |
| Total assets | $2.4B | $3.4B | $3.4B | $3.5B | $3.7B | $3.8B | $3.8B | $5.3B | $6.0B | $5.9B |
| Total liabilities | $1.6B | $2.3B | $2.0B | $1.9B | $1.9B | $1.6B | $1.5B | $2.7B | $3.1B | $2.9B |
| Shareholders' equity | $852M | $1.2B | $1.5B | $1.6B | $1.8B | $2.2B | $2.3B | $2.6B | $2.9B | $3.0B |
| Margins | ||||||||||
| Gross margin | 54.9% | 55.1% | 54.8% | 54.3% | 53.3% | 56.1% | 55.1% | 54.2% | 55.3% | 55.2% |
| Operating margin | 21.5% | 22.6% | 22.3% | 22.0% | 16.5% | 26.0% | 27.1% | 25.6% | 25.1% | 25.5% |
| EBITDA margin | 25.4% | 27.0% | 27.1% | 27.0% | 21.8% | 30.4% | 31.0% | 27.9% | 27.9% | 28.3% |
| Net margin | 15.0% | 14.3% | 16.7% | 15.4% | 11.8% | 19.2% | 19.8% | 18.6% | 17.4% | 17.4% |
| FCF margin | 15.1% | 13.8% | 18.4% | 14.5% | 21.3% | 21.5% | 17.8% | 23.1% | 18.3% | 23.7% |
| Returns | ||||||||||
| Return on capital | 16.4% | 14.9% | 15.9% | 14.1% | 10.8% | 18.1% | 19.9% | 15.0% | 11.6% | 11.6% |
| Return on capital employed | 18.7% | 19.2% | 17.2% | 15.8% | 11.0% | 18.5% | 22.2% | 17.6% | 13.3% | 13.4% |
| Return on equity | 36.0% | 29.5% | 29.0% | 22.2% | 14.9% | 23.2% | 23.0% | 19.9% | 16.9% | 16.2% |
| Return on assets | 11.4% | 10.1% | 11.0% | 9.7% | 6.9% | 12.2% | 13.5% | 10.8% | 8.3% | 8.1% |
| Growth | ||||||||||
| Revenue growth | 7.1% | 14.3% | 9.1% | β2.7% | β3.3% | 11.4% | 9.7% | 1.5% | 2.3% | 3.8% |
| Net income growth | 28.8% | 8.8% | 27.6% | β10.7% | β26.0% | 82.1% | 12.9% | β5.0% | β4.2% | 3.7% |
| EPS growth | 37.1% | 7.4% | 26.0% | β9.5% | β26.3% | 81.3% | 13.8% | β4.0% | β4.1% | 4.9% |
| FCF growth | 37.0% | 4.2% | 45.5% | β23.2% | 41.8% | 12.3% | β9.1% | 31.4% | β18.9% | 34.4% |
| Share count change | β5.9% | 1.2% | 1.3% | β1.2% | 0.5% | 0.5% | β0.8% | β1.1% | β0.0% | β1.2% |
| Financial health | ||||||||||
| Net debt / EBITDA | 2.0x | 2.7x | 2.0x | 1.9x | 2.0x | 0.7x | 0.7x | 2.2x | 2.8x | 2.4x |
| Debt / equity | 1.2x | 1.4x | 0.9x | 0.8x | 0.6x | 0.4x | 0.3x | 0.7x | 0.8x | 0.7x |
| Interest coverage | 18.2x | 12.7x | 10.1x | 10.3x | 10.9x | 24.1x | 31.3x | 11.3x | 7.6x | 6.8x |
| Current ratio | 2.3x | 1.4x | 2.5x | 2.1x | 2.8x | 2.6x | 1.4x | 2.1x | 2.4x | 1.6x |
| Quick ratio | 1.6x | 1.0x | 1.8x | 1.5x | 2.1x | 1.9x | 0.9x | 1.3x | 1.5x | 1.1x |
| Capital allocation | ||||||||||
| Capex / revenue | 3.4% | 3.5% | 4.0% | 2.9% | 2.4% | 1.6% | 2.0% | 1.3% | 2.4% | 2.1% |
| Stock comp / revenue | 1.0% | 1.0% | 1.0% | 0.8% | 0.6% | 1.0% | 1.2% | 0.9% | 0.7% | 0.7% |
| Payouts / FCF | 32.8% | 23.5% | 23.3% | 63.6% | 31.2% | 31.3% | 84.2% | 39.6% | 39.6% | 73.4% |
| Quality scores | ||||||||||
| Piotroski F-score | 8.0 | 6.0 | 5.0 | 5.0 | 5.0 | 7.0 | 7.0 | 6.0 | 6.0 | 5.0 |
| Altman Z'' | 5.4 | 4.0 | 5.2 | 5.3 | 5.4 | 6.5 | 6.4 | 5.2 | 4.9 | 5.0 |
| Accruals ratio | β2.6% | β2.1% | β3.7% | β1.3% | β7.0% | β2.5% | 0.0% | β3.4% | β1.6% | β3.9% |
Source: SEC EDGAR XBRL filings (CIK 0000072331). Data updated October 9, 2026. Quarterly fourth quarters are the full year minus the first nine months. For information only β not investment advice. Check the original filings before relying on any figure.